SERCA2a activator A
CAS No. 2139330-34-8
SERCA2a activator A ( Compound A )
产品货号. M13416 CAS No. 2139330-34-8
SERCA2a activator A 是一种新型肌/内质网 Ca2+ 依赖性 ATPase 2a (SERCA2a) 激活剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4722 | 有现货 |
|
| 10MG | ¥6622 | 有现货 |
|
| 25MG | ¥9179 | 有现货 |
|
| 50MG | ¥12927 | 有现货 |
|
| 100MG | ¥16920 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥5681 | 有现货 |
|
生物学信息
-
产品名称SERCA2a activator A
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SERCA2a activator A 是一种新型肌/内质网 Ca2+ 依赖性 ATPase 2a (SERCA2a) 激活剂。
-
产品描述SERCA2a activator A is a novel sarco/endoplasmic reticulum Ca2+-dependent ATPase 2a (SERCA2a) activator that activates the Ca2+-dependent ATPase activity of cardiac SR vesicles but not that of skeletal muscle SR vesicles that lack of phospholamban (PLN); binds to PLN (Kd=75 uM), attenuates its inhibition of SERCA2a; enhances systolic and diastolic functions in rat hearts.
-
体外实验SERCA2a activator 1 (Compound A) activates the Ca2+-dependent ATPase activity of cardiac sarcoplasmic reticulum (SR) vesicles but not that of skeletal muscle SR vesicles that lack phospholamban (PLN). The surface plasmon resonance assay reveals a direct interaction between SERCA2a activator 1 and PLN, suggesting that the binding of SERCA2a activator 1 to PLN attenuates its inhibition of SERCA2a, resulting in SERCA2a activation. SERCA2a activator 1 also increases the Ca2+ transients and contraction and relaxation of isolated adult rat cardiomyocytes. In isolated perfused rat hearts, the SERCA2a activator 1 enhances systolic and diastolic functions.
-
体内实验SERCA2a activator 1 (Compound A; 30mg/kg; intravenous injection; male Wistar rats) treatment significantly enhances the diastolic function in anesthetized normal rats. Animal Model:Male Wistar rats (7-8 weeks old) Dosage:30mg/kg Administration:Intravenous injection Result:Significantly enhanced the diastolic function in anesthetized normal rats.
-
同义词Compound A
-
通路GPCR/G Protein
-
靶点Calcium Channel
-
受体Calcium Channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number2139330-34-8
-
分子量551.661
-
分子式C32H29N3O4S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 62.5 mg/mL (113.29 mM)
-
SMILESO=C(C1=CC(C(C=C2CC3=CC=CC=C3)=CN(CCCC)C2=O)=NC=C1)NS(=O)(C4=CC=C5C=CC=CC5=C4)=O
-
化学全称5'-benzyl-1'-butyl-N-(naphthalen-2-ylsulfonyl)-6'-oxo-1',6'-dihydro-[2,3'-bipyridine]-4-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kaneko M, et al. Eur J Pharmacol. 2017 Nov 5;814:1-8.
产品手册
关联产品
-
Lercanidipine
乐卡地平是二氢吡啶类钙通道阻滞剂。
-
Coptisine sulfate
在NCI的抗癌药物筛选计划中,硫酸黄连碱对人类癌细胞系具有生长抑制活性。
-
Vatanidipine
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
021-51111890
购物车()
sales@molnova.cn

